Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Dbv Technologies S.a. (DBVT) since 2022 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Dbv Technologies S.a.. Table 2 shows the detailed insider transactions. This company's CIK number is 1613780.
Total stock buying since 2022: $58,352.
Total stock sales since 2022: $17,438.
Total stock option exercises since 2022: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 1,461 | $2,270 | 0 | $0 |
| 2024 | 18,919 | $15,812 | 5,177 | $4,442 | 0 | $0 |
| 2023 | 27,000 | $42,540 | 2,714 | $5,566 | 0 | $0 |
| 2022 | 0 | $0 | 1,792 | $5,160 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-07 | 0 | $0 | 464 | $1,030 | 0 | $0 |
| 2025-05 | 0 | $0 | 397 | $730 | 0 | $0 |
| 2025-01 | 0 | $0 | 600 | $510 | 0 | $0 |
| 2024-11 | 0 | $0 | 2,350 | $1,269 | 0 | $0 |
| 2024-07 | 0 | $0 | 1,785 | $1,749 | 0 | $0 |
| 2024-05 | 0 | $0 | 1,042 | $1,424 | 0 | $0 |
| 2024-03 | 17,094 | $14,188 | 0 | $0 | 0 | $0 |
| 2024-02 | 1,825 | $1,624 | 0 | $0 | 0 | $0 |
| 2023-11 | 0 | $0 | 2,245 | $3,906 | 0 | $0 |
| 2023-08 | 27,000 | $42,540 | 0 | $0 | 0 | $0 |
| 2023-05 | 0 | $0 | 469 | $1,660 | 0 | $0 |
| 2022-11 | 0 | $0 | 1,792 | $5,160 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-07-29 | Mohideen Pharis (Chief Medical Officer) | Sale | 464 | 2.22 | 1,030 |
| 2025-05-22 | Mohideen Pharis (Chief Medical Officer) | Sale | 397 | 1.84 | 730 |
| 2025-01-30 | Mohideen Pharis (Chief Medical Officer) | Sale | 600 | .85 | 510 |
| 2024-11-21 | Mohideen Pharis (Chief Medical Officer) | Sale | 2,350 | .54 | 1,269 |
| 2024-07-29 | Mohideen Pharis (Chief Medical Officer) | Sale | 1,785 | .98 | 1,749 |
| 2024-05-24 | Mohideen Pharis (Chief Medical Officer) | Sale | 660 | 1.36 | 897 |
| 2024-05-22 | Mohideen Pharis (Chief Medical Officer) | Sale | 382 | 1.38 | 527 |
| 2024-03-08 | Tasse Daniel (CHIEF EXECUTIVE OFFICER) | Buy | 17,094 | .83 | 14,188 |
| 2024-02-06 | Ndu Adora | Buy | 1,825 | .89 | 1,624 |
| 2023-11-22 | Mohideen Pharis (Chief Medical Officer) | Sale | 2,245 | 1.74 | 3,906 |
| 2023-08-25 | Morris Timothy E (Director) | Buy | 12,000 | 1.52 | 18,240 |
| 2023-08-01 | Soland Daniel B (Director) | Buy | 15,000 | 1.62 | 24,300 |
| 2023-05-24 | Mohideen Pharis (Chief Medical Officer) | Sale | 469 | 3.54 | 1,660 |
| 2022-11-24 | Mohideen Pharis (Chief Medical Officer) | Sale | 1,792 | 2.88 | 5,160 |
Insider trading activities including stock purchases, stock sales, and option exercises of DBVT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Dbv Technologies S.a. (symbol DBVT, CIK number 1613780) see the Securities and Exchange Commission (SEC) website.